Paediatric onset of multiple sclerosis: Analysis of chemokine and cytokine levels in the context of the early clinical course
Authors:
- 1 November 2020
- journal article
- research article
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 46, 102467
Abstract
No abstract availableKeywords
Funding Information
- Ministerstvo Zdravotnictví Ceské Republiky
- Grantová Agentura, Univerzita Karlova
This publication has 34 references indexed in Scilit:
- Pediatric multiple sclerosis: a reviewBMC Neurology, 2018
- Neutrophil perversion in demyelinating autoimmune diseases: Mechanisms to medicineAutoimmunity Reviews, 2017
- Prognostic indicators of secondary progression in a paediatric-onset multiple sclerosis cohort in KuwaitMultiple Sclerosis Journal, 2015
- Elevated relapse rates in pediatric compared to adult MS persist for at least 6 yearsMultiple Sclerosis and Related Disorders, 2014
- International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitionsMultiple Sclerosis Journal, 2013
- Cerebrospinal Fluid IL-12p40, CXCL13 and IL-8 as a Combinatorial Biomarker of Active Intrathecal InflammationPLOS ONE, 2012
- Younger children with MS have a distinct CSF inflammatory profile at disease onsetNeurology, 2010
- Increased Relapse Rate in Pediatric-Onset Compared With Adult-Onset Multiple SclerosisArchives of Neurology, 2009
- The levels of chemokines CXCL8, CCL2 and CCL5 in multiple sclerosis patients are linked to the activity of the diseaseEuropean Journal of Neurology, 2004
- Multiple sclerosis in childhood: clinical features of 149 casesMultiple Sclerosis Journal, 1997